✨ Innovation alert: CellEKT, developed by the lab of Oncode Investigator Mario van der Stelt & Oncode Researcher Joel Rüegger (both at @unileiden.bsky.social ), uses advanced probes to profile kinase inhibitor selectivity, supporting safer, targeted cancer therapies. Read more: lnkd.in/gxCBtu7W
